Rating Change
BTIG reiterated its Buy rating on LENSAR, Inc. (NASDAQ:LNSR) on August 20, 2026.
BTIG reiterated its Buy rating on LENSAR, Inc. (NASDAQ:LNSR) on August 20, 2026.

At publication ·
LENSAR, Inc. (NASDAQ:LNSR) · reiterate
At a glance
BTIG reiterated its Buy rating on LENSAR, Inc. (NASDAQ:LNSR) on August 20, 2026.
LENSAR, Inc. operates in the Healthcare sector. The stock currently trades at $8.51 with a market capitalization of $137.6M.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for LENSAR, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 8 most recent ratings: 7 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | BTIG | Buy | N/A |
| Aug 13, 2026 | BTIG | Buy | N/A |
| Mar 18, 2026 | BTIG | Buy | N/A |
| Mar 24, 2025 | Lake Street | Hold | N/A |
| Feb 28, 2025 | Lake Street | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View LNSR Stock Page
A rating of Buy from BTIG reflects the analyst's outlook on LENSAR, Inc. (NASDAQ:LNSR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LNSR forecast page.
Current market data
NASDAQ · LNSR
$8.31
Down: -$0.26 · -3.13%
Live quote updated
Keep reading